Search Results 1041-1050 of 17630 for treatment resistant depression

  1. A Study to Evaluate the Effects of the Authentic Connections Program on Resilience, Psychological Distress, Depression, Self-compassion, Parenting Stress, and Burnout in Nurse Leaders - Mayo Clinic

    Outcomes that will be measured include: psychological distress, depression, self-compassion, parenting stress, burnout, and feasibility measures. Participation ...

  2. Clinical trials - Oncology (Medical)

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study of ...

  3. Cancer Clinical Trials - Medical Professionals

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study ...

  4. Clinical trials - Oncology (Medical)

    ... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. BiCaZO: A Study Combining Two Immunotherapies ...

  5. Big data helps in understanding asthma biologic use, outcomes - Mayo Clinic News Network

    "This can cause treatment ... No COPD or depression comorbidities; Medicare ... Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory ...

  6. Dronabinol (oral route) - Side effects & dosage - Mayo Clinic

    Description. Dronabinol is used to treat nausea and vomiting caused by cancer medicines. It is used only when other kinds of medicine for nausea and ...

  7. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary ...

  8. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    * Patients must have relapsed or refractory disease after at least two prior lines of therapy and lack additional standard options with survival benefit: A)LBCL ...

  9. Medical Research & Education - Mayo Clinic News Network

    ... treatment resistance can lead to new hope for some featured. Cancer. Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some.

  10. Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study - Mayo Clinic

    By condition, treatment or drug name. Search tips ... treatment has been approved and is on the market. ... (depression and bipolar disorder) and cognitive ...